Journal of Clinical Oncology and Cancer Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 7480022681

Commentary - Journal of Clinical Oncology and Cancer Research (2022) Volume 5, Issue 3

Resistance to therapies, and rapid spreading of pancreatic ductal adenocarcinoma associated with a poor prognosis

Most patients are ineligible for reparable medical procedure as they present with cutting edge illness at the hour of finding. Present indicative techniques depending on physical changes have different impediments including trouble to separate among harmless and dangerous circumstances, intrusiveness, the equivocalness of imaging results, or the failure to identify sub-atomic biomarkers of PDAC inception and movement. Subsequently, new imaging advancements with high awareness and particularity are fundamentally required for precisely identifying PDAC and harmlessly portraying sub-atomic elements driving its pathogenesis. Contrast improved designated ultrasound (CETUS) is a forthcoming sub-atomic imaging methodology that explicitly resolves these issues. Not at all like physical imaging modalities, for example, CT and MRI, sub-atomic imaging utilizing CETUS is promising for ahead of schedule and exact discovery of PDAC. The utilization of microscopically focused on microbubbles that tight spot to neovascular targets can upgrade the ultrasound signal explicitly from harmful PDAC tissues

Author(s): Zhen Yang

Abstract Full Text PDF

Get the App